Ranbaxy gets FDA nod for clarithromycin
Ranbaxy is the first company to have been granted a generic approval for the oral suspension form along with clarithromycin tablets.
By PTI |
NEW DELHI: Ranbaxy Pharmaceuticals Inc said Ranbaxy Laboratories Ltd received US health regulators' approval to manufacture and market the oral suspension of clarithromycin, for treating certain bacterial infections.
Ranbaxy is the first company to have been granted a generic approval for the oral suspension form along with clarithromycin tablets, it said in a statement.
Ranbaxy is the first company to have been granted a generic approval for the oral suspension form along with clarithromycin tablets, it said in a statement.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
